Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7251
CALL
Galectin Therapeutics
GALT
$354M
| $104K | ﹤0.01% |
31,200
+10,000
| +47% | +$25.3K |
|
7252
Lee Enterprises
LEE
$186M
| $104K | ﹤0.01% |
4,408
+3,020
| +218% | +$70.8K |
|
7253
CALL
Anavex Life Sciences
AVXL
$294M
| $103K | ﹤0.01% |
31,900
+19,400
| +155% | +$76.4K |
|
7254
CALL
AXT Inc
AXTI
$5.2B
| $103K | ﹤0.01% |
11,800
+700
| +6% | +$6.4K |
|
|
7255
PUT
AXT Inc
AXTI
$5.2B
| $103K | ﹤0.01% |
+11,800
| New | +$108K |
|
|
NH
7256
DELISTED
NantHealth, Inc
NH
| $103K | ﹤0.01% |
+2,260
| New | +$120K |
|
|
SORL
7257
PUT
DELISTED
SORL Auto Parts, Inc.
SORL
| $103K | ﹤0.01% |
+15,400
| New | +$92.4K |
|
7258
CALL
Build-A-Bear
BBW
$479M
| $102K | ﹤0.01% |
+11,100
| New | +$94.7K |
|
7259
PUT
LXP Industrial Trust
LXP
$3.57B
| $102K | ﹤0.01% |
+2,120
| New | +$109K |
|
|
XXII
7260
CALL
22nd Century Group
XXII
$1.5M
| – | – |
0
| – | – |
|
|
MEET
7261
CALL
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $102K | ﹤0.01% |
36,100
+9,800
| +37% | +$29.2K |
|
7262
Pixelworks
PXLW
$44.5M
| $101K | ﹤0.01% |
1,328
-1,168
| -47% | -$79.1K |
|
7263
PUT
Sunrun
RUN
$2.43B
| $101K | ﹤0.01% |
17,100
-7,200
| -30% | -$41.4K |
|
7264
CALL
Accuray
ARAY
$33.7M
| $100K | ﹤0.01% |
+23,200
| New | +$107K |
|
7265
Century Casinos
CNTY
$35.7M
| $100K | ﹤0.01% |
+10,959
| New | +$95.3K |
|
7266
CALL
Globalstar
GSAT
$10.6B
| $100K | ﹤0.01% |
5,093
-787
| -13% | -$17.9K |
|
7267
PUT
Safe Bulkers
SB
$791M
| $100K | ﹤0.01% |
31,000
+11,300
| +57% | +$36.3K |
|
|
WIN
7268
CALL
DELISTED
Windstream Holdings Inc
WIN
| $100K | ﹤0.01% |
10,840
-3,760
| -26% | -$38.5K |
|
|
AGEN
7269
CALL
Agenus
AGEN
$330M
| $99K | ﹤0.01% |
1,549
+87
| +6% | +$6.64K |
|
|
AGEN
7270
PUT
Agenus
AGEN
$330M
| $99K | ﹤0.01% |
1,544
+214
| +16% | +$16.3K |
|
7271
PUT
CEMIG Preferred Shares
CIG
$5.55B
| $99K | ﹤0.01% |
94,755
+65,328
| +222% | +$74.2K |
|
|
RLH
7272
DELISTED
Red Lions Hotel Corporation
RLH
| $99K | ﹤0.01% |
+10,062
| New | +$89.7K |
|
|
VSI
7273
PUT
DELISTED
Vitamin Shoppe Inc.
VSI
| $99K | ﹤0.01% |
22,400
-19,400
| -46% | -$85.4K |
|
|
HIVE
7274
DELISTED
Aerohive Networks
HIVE
| $99K | ﹤0.01% |
16,998
-12,751
| -43% | -$61.4K |
|
7275
Camtek
CAMT
$7.6B
| $98K | ﹤0.01% |
+17,107
| New | +$99.1K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.